Semaglutide Tablets
A daily oral tablet that mimics GLP-1 — the gut hormone that regulates blood sugar, slows digestion, and signals fullness. Prescribed online by U.S. licensed doctors with a same-day assessment, custom-dosed for you by a state-licensed compounding pharmacy, and delivered free in about 2 days. From $299/month, HSA/FSA eligible.
What are compounded semaglutide tablets?
Compounding means creating a medication tailored to an individual — for instance, an oral tablet version of a medication, or a customized dose your doctor prescribes for you specifically. Compounded medications are prepared by state-licensed compounding pharmacies operating under state board of pharmacy oversight and required to meet USP compounding standards.
Compounded semaglutide tablets are not approved by the FDA, and the FDA does not review compounded medications for safety, effectiveness, or quality. They are not brand-equivalent. Prefer an FDA-approved product? We also offer Wegovy pills and the Wegovy injection — your doctor can help you choose at your free assessment.
How semaglutide tablets work
When you eat, your gut releases GLP-1 — a hormone that triggers insulin, slows digestion, and tells your brain you're full. In some people that signal runs weak. Semaglutide is a synthetic GLP-1 receptor agonist: it activates the same receptors as your natural hormone, restoring the signal.
Curbs hunger
By activating GLP-1 receptors in the gut and brain, semaglutide quiets the constant food chatter — patients commonly report the random snack cravings simply stop showing up.
Slows digestion
Food leaves your stomach more gradually, so smaller portions feel as satisfying as large ones used to, and fullness lasts noticeably longer after meals.
Steadies blood sugar
Semaglutide triggers insulin release when glucose rises, smoothing the spikes and crashes that drive between-meal cravings and energy dips.
Semaglutide Tablets
Doctor-prescribed medication, custom-dosed for you. Free assessment included — and you're only charged after a licensed doctor approves your prescription.
- Same-day prescriptions when you qualify
- Free discreet 2-day shipping
- HSA / FSA eligible
- Prepared by state-licensed compounding pharmacies (USP standards)
- Doctor-guided dose adjustments by message — no appointment needed
- 7-day support from real humans
Compounded tablet or FDA-approved brand?
Both paths run through the same free doctor assessment. The compounded tablet offers dosing customized to you; the brand products carry FDA approval and manufacturer consistency. Your doctor lays out the trade-offs honestly — the right answer depends on your history, goals, and budget.
- Compounded semaglutide tablets — from $299/mo, custom-dosed
- Wegovy pills (FDA-approved oral) — from $149/mo
- Wegovy injection (FDA-approved weekly) — from $149/mo
- Tirzepatide program (dual-action) — from $299/mo
- Full comparison: brand vs compounded guide
Three simple steps to weight loss care
Free assessment
Quick questions about your health history and goals determine eligibility — with same-day assessment slots and nothing charged for the consultation.
Choose your treatment
A U.S. licensed doctor reviews your answers, discusses compounded tablets versus FDA-approved options, and confirms your prescription the same day you qualify.
Move forward with confidence
Monthly medication arrives with free, discreet 2-day shipping — with dose adjustments, refills, and the care team a message away, 7 days a week.
Managed titration, responsive care
Some patients experience side effects on semaglutide — nausea is the most common, along with constipation, diarrhea, and stomach discomfort, typically strongest in the early weeks and after dose increases, and usually subsiding as your body adjusts. That's why dosing starts low and climbs gradually: your doctor balances weight loss with comfort, and adjusts the plan by message with no appointment required. If needed, your doctor can also prescribe an anti-nausea medication such as generic ondansetron. Serious semaglutide-class risks — pancreatitis, gallbladder disease, and the thyroid C-cell boxed warning that applies across semaglutide products — are exactly what your consultation screens for; see the full details in our side effects guide and the disclosures below.
What members say
My doctor is helpful and quick to respond, and shipping has been on time every month. One early hiccup with a missing tablet was fixed within days by the care team.
Communication has been great with the doctors and staff, and I've always received my medication in a timely manner.
I'm on maintenance, not starting out, and I was surprised how welcome my goals were — other sites only wanted to prescribe for a starting BMI, not help me keep the weight off.
From the doctors to the staff everyone is responsive — I'm almost to my goal weight, down 25 lbs, and I've referred a friend who's having a great experience too.
Testimonials reflect individual experiences with our weight loss programs. Results vary and are not guaranteed — weight loss depends on dose, adherence, diet, and physical activity. Not everyone qualifies for treatment.
Looking for a dual-action solution?
By targeting both GLP-1 and GIP, tirzepatide offers a dual-hormone approach built around your individual health goals — from $299/month with the same free doctor assessment.
Explore TirzepatideSemaglutide tablets — frequently asked questions
Important Safety Information & Disclaimers
Compounded medication disclosure
WegovyPills.org is a telehealth platform that connects patients with independent, licensed physicians. Prescription medications, including compounded medications, are available only if prescribed after an online consultation with a licensed physician. Compounded semaglutide is not approved by the FDA, and the FDA does not review compounded medications for safety, effectiveness, or quality. These medications are prepared by state-licensed compounding pharmacies that operate under state board of pharmacy oversight and are required to meet USP compounding standards. Compounded medications are not brand-equivalent. WegovyPills.org is not the compounding pharmacy or manufacturer. Prescription product availability varies by state.
About treatment results
Individual results vary and are not guaranteed. Published semaglutide efficacy data come from trials of FDA-approved semaglutide products (for example, STEP 1: 14.9% average weight loss over 68 weeks with weekly 2.4 mg; Wilding et al., NEJM 2021), conducted alongside diet and activity changes. Compounded semaglutide tablets have not been the subject of those trials, and their results may differ.
Boxed warning and serious risks (semaglutide class)
Semaglutide carries a boxed warning: in rodent studies it caused thyroid C-cell tumors, and it is not known whether it causes medullary thyroid carcinoma (MTC) in humans. Do not use semaglutide if you or a family member has a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other serious risks include pancreatitis, gallbladder disease, kidney injury, hypoglycemia with certain diabetes medications, severe allergic reactions, and mood changes — monitor for new or worsening depression or suicidal thoughts, contact your provider promptly if they occur, and in the U.S. call or text 988 in a mental-health emergency. Do not use during pregnancy or while breastfeeding. Common side effects include nausea, diarrhea, vomiting, constipation, and stomach discomfort. If you are experiencing a medical emergency, call 911.
Reporting side effects
Suspected adverse reactions can be reported to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
Scope of this page
This content is informational only and does not constitute medical advice, diagnosis, or treatment. Pricing reflects our platform; HSA/FSA eligibility depends on your plan administrator. Always consult a licensed healthcare provider for personal medical decisions.
Sources
- Human Drug Compounding — U.S. Food & Drug Administration
- Wegovy® (semaglutide) Prescribing Information — FDA
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — NEJM, 2021
- Postmarket Drug Safety Information — FDA
Trademarks
Wegovy®, Ozempic®, and Rybelsus® are registered trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Compounded semaglutide is not associated with, manufactured by, or endorsed by these companies. This website is independently operated and not affiliated with Novo Nordisk or Eli Lilly.
Start your free assessment today.
Quick questions, a same-day review by a U.S. licensed doctor, and free 2-day shipping if you're approved — with every option, compounded or FDA-approved, on the table. You're only charged after approval.
Book an Appointment